Benitec Biopharma's 15min chart triggers MACD Death Cross and Bearish Marubozu
PorAinvest
miércoles, 10 de septiembre de 2025, 11:10 am ET4 min de lectura
ALGT--
The MACD (Moving Average Convergence Divergence) Death Cross is a technical indicator that signals a change in the trend of a security. When the MACD line crosses below the signal line, it indicates a bearish signal. The Bearish Marubozu pattern, characterized by a large body with minimal wicks, further supports this bearish trend, signaling strong selling conviction [1].
According to the 15-minute chart, the Bollinger Bands are currently expanding downward, indicating an increase in market volatility. The bearish Marubozu candlestick pattern, which was observed on September 9, 2025, at 13:00, aligns with the broader market conditions, suggesting that sellers are in control and that the downtrend is likely to persist .
Investors should closely monitor Benitec Biopharma's financial performance and technical indicators to make informed decisions. While these technical signals provide insights into potential stock price movements, investors should consider these signals in conjunction with fundamental analysis and broader market conditions.
Positive Outlook:
- Alnylam Pharma (ALNY) received a "Buy" rating from Jefferies with a price target of $384.00 [1].
- Chime Financial (CHYM) was initiated with an "Overweight" rating by multiple firms, including Morgan Stanley and Barclays, with targets ranging from $39.00 to $40.00 [1].
- CryoPort (CYRX) was rated "Buy" by BTIG Research with a price target of $10.00 [1].
- Datadog (DDOG) had its price target raised from $150.00 to $175.00 by Bank of America, reiterating a "Buy" rating [1].
- Energy Transfer (ET) was initiated with a "Buy" rating by TD Cowen with a price target of $22.00 [1].
- Grab (GRAB) was rated "Buy" by Jefferies with a price target of $5.70, indicating a 20.94% upside [1].
- Home Depot (HD) was rated "Buy" by TD Cowen with a price target of $470.00 [1].
- Intuit (INTU) was rated "Buy" by Morgan Stanley with a price target of $900.00 [1].
- JPMorgan Chase & Co. (JPM) had a $298.00 target set by Evercore ISI with an "Outperform" rating [1].
- Kinder Morgan (KMI) was initiated with a "Buy" rating by TD Cowen [1].
- Lam Research (LRCX) had its "Buy" rating reiterated by Citigroup [1].
- MACOM Technology Solutions (MTSI) had its target raised from $136.00 to $154.00 by Truist Financial, maintaining a "Buy" rating [1].
- Monopar Therapeutics (MNPR) was initiated with an "Overweight" rating by Cantor Fitzgerald and a target of $74.00 [1].
- Norwegian Cruise Line (NCLH) received a "Buy" rating from Jefferies with a price target of $29.00 [1].
- Oracle (ORCL) received a "Buy" rating from UBS with a $250.00 target [1].
- Oportun Financial (OPRT) was rated "Buy" at B. Riley Financial with an $11.00 price target [1].
- Ovintiv (OVV) was rated "Buy" at Barclays Capital with a price target of $55.00 [1].
- Phibro Animal Health (PAHC) was upgraded at JPMorgan Chase from Neutral to Overweight, with the price target raised from $25.00 to $35.00 [1].
- Progressive (PGR) was downgraded by Morgan Stanley from Overweight to Equal Weight, with a price target of $290.00 [1].
- Pulse Biosciences (PLSE) was initiated by Oppenheimer with an "Outperform" rating and a $22.00 price target [1].
- PTC (PTC) had its Overweight rating reiterated by KeyCorp Bank [1].
- Rockwell Automation (ROK) was initiated by CICC Research with a "Buy" rating and a price target of $320.00 [1].
Neutral Outlook:
- Allegiant Travel (ALGT) was initiated with a Neutral rating by UBS Group, with a price target lowered from $60.00 to $59.00 [1].
- Alaska Air Group (ALK) was initiated with a Neutral rating and a $49.00 price target by UBS Group [1].
- AvalonBay (AVB) was rated "Hold" by Evercore ISI with a price target of $229.00 [1].
- Benitec Biopharma (BNTC) was initiated with a "Buy" rating by TD Cowen [1].
- Broadridge Financial Solutions (BR) received a "Hold" rating from D.A. Davidson with a $220.00 target [1].
- Camden Property (CPT) was rated "Hold" by Evercore ISI with a price target of $124.00, implying a 13.26% upside [1].
- Citigroup (C) had a price target of $77.00 set by Evercore ISI, while Oppenheimer reiterated an "Outperform" rating [1].
- Coinbase Global (COIN) received a "Hold" rating from Goldman Sachs with a $268.00 price target [1].
- Coterra Energy (CTRA) was assigned a "Buy" rating by Barclays Capital with a $37.00 target [1].
- Crexendo (CXDO) was rated "Buy" at Northland Securities with a price target of $8.00 [1].
- Datadog (DDOG) had its price target raised from $150.00 to $175.00 by Bank of America, reiterating a "Buy" rating [1].
- DoubleVerify (DV) had its "Buy" rating reiterated by Craig Hallum [1].
- Emerson Electric Company (EMR) was rated "Buy" by TD Cowen, with a price target of $150.00 [1].
- Enovix (ENVX) received a "Buy" rating from Northland Securities with a $25.00 target [1].
- Enterprise Products Partners (EPD) was initiated with a "Hold" rating and a $33.00 price target by TD Cowen [1].
- Equity Residential (EQR) was upgraded by Evercore ISI from In-Line to Outperform, with a new target of $75.00, up from $74.00 [1].
- EQT Corp. (EQT) was initiated with an Overweight rating and a $65.00 target by Barclays [1].
- Essex Property (ESS) was rated "Hold" by Evercore ISI with a price target of $296.00 [1].
- Essent Group (ESNT) was downgraded from Outperform to Market Perform by Keefe, Bruyette & Woods, with a price target of $67.00 [1].
- Expand Energy (EXE) received a "Buy" rating from Northland Securities with a $25.00 target [1].
- First Republic Bank (FRC) was downgraded by Jefferies from Overweight to Hold, with a price target of $24.00 [1].
- Fiserv (FISV) was upgraded by Raymond James from Market Perform to Outperform, with a new target of $180.00, up from $175.00 [1].
- Five Below (FIVE) was rated "Hold" by Wedbush with a price target of $140.00 [1].
- Flextronics International (FLEX) was initiated with a "Buy" rating by Northland Securities with a price target of $15.00 [1].
- Global Payments (GPAY) was rated "Buy" by TD Cowen with a price target of $120.00 [1].
- HCA Healthcare (HCA) was rated "Buy" by TD Cowen with a price target of $340.00 [1].
Investors should remain cautious and monitor the stock closely for any changes in the technical indicators.
ALK--
ALNY--
AVB--
BAC--
Benitec Biopharma's 15-minute chart has recently exhibited a MACD Death Cross and a Bearish Marubozu pattern, which suggests a high likelihood of a continued decline in the stock price. The bearish momentum appears to be sustained, with sellers dominating the market. This trend is expected to persist in the near term.
Benitec Biopharma's 15-minute chart has recently exhibited a MACD Death Cross and a Bearish Marubozu pattern, suggesting a high likelihood of a continued decline in the stock price. The bearish momentum appears to be sustained, with sellers dominating the market. This trend is expected to persist in the near term.The MACD (Moving Average Convergence Divergence) Death Cross is a technical indicator that signals a change in the trend of a security. When the MACD line crosses below the signal line, it indicates a bearish signal. The Bearish Marubozu pattern, characterized by a large body with minimal wicks, further supports this bearish trend, signaling strong selling conviction [1].
According to the 15-minute chart, the Bollinger Bands are currently expanding downward, indicating an increase in market volatility. The bearish Marubozu candlestick pattern, which was observed on September 9, 2025, at 13:00, aligns with the broader market conditions, suggesting that sellers are in control and that the downtrend is likely to persist .
Investors should closely monitor Benitec Biopharma's financial performance and technical indicators to make informed decisions. While these technical signals provide insights into potential stock price movements, investors should consider these signals in conjunction with fundamental analysis and broader market conditions.
Positive Outlook:
- Alnylam Pharma (ALNY) received a "Buy" rating from Jefferies with a price target of $384.00 [1].
- Chime Financial (CHYM) was initiated with an "Overweight" rating by multiple firms, including Morgan Stanley and Barclays, with targets ranging from $39.00 to $40.00 [1].
- CryoPort (CYRX) was rated "Buy" by BTIG Research with a price target of $10.00 [1].
- Datadog (DDOG) had its price target raised from $150.00 to $175.00 by Bank of America, reiterating a "Buy" rating [1].
- Energy Transfer (ET) was initiated with a "Buy" rating by TD Cowen with a price target of $22.00 [1].
- Grab (GRAB) was rated "Buy" by Jefferies with a price target of $5.70, indicating a 20.94% upside [1].
- Home Depot (HD) was rated "Buy" by TD Cowen with a price target of $470.00 [1].
- Intuit (INTU) was rated "Buy" by Morgan Stanley with a price target of $900.00 [1].
- JPMorgan Chase & Co. (JPM) had a $298.00 target set by Evercore ISI with an "Outperform" rating [1].
- Kinder Morgan (KMI) was initiated with a "Buy" rating by TD Cowen [1].
- Lam Research (LRCX) had its "Buy" rating reiterated by Citigroup [1].
- MACOM Technology Solutions (MTSI) had its target raised from $136.00 to $154.00 by Truist Financial, maintaining a "Buy" rating [1].
- Monopar Therapeutics (MNPR) was initiated with an "Overweight" rating by Cantor Fitzgerald and a target of $74.00 [1].
- Norwegian Cruise Line (NCLH) received a "Buy" rating from Jefferies with a price target of $29.00 [1].
- Oracle (ORCL) received a "Buy" rating from UBS with a $250.00 target [1].
- Oportun Financial (OPRT) was rated "Buy" at B. Riley Financial with an $11.00 price target [1].
- Ovintiv (OVV) was rated "Buy" at Barclays Capital with a price target of $55.00 [1].
- Phibro Animal Health (PAHC) was upgraded at JPMorgan Chase from Neutral to Overweight, with the price target raised from $25.00 to $35.00 [1].
- Progressive (PGR) was downgraded by Morgan Stanley from Overweight to Equal Weight, with a price target of $290.00 [1].
- Pulse Biosciences (PLSE) was initiated by Oppenheimer with an "Outperform" rating and a $22.00 price target [1].
- PTC (PTC) had its Overweight rating reiterated by KeyCorp Bank [1].
- Rockwell Automation (ROK) was initiated by CICC Research with a "Buy" rating and a price target of $320.00 [1].
Neutral Outlook:
- Allegiant Travel (ALGT) was initiated with a Neutral rating by UBS Group, with a price target lowered from $60.00 to $59.00 [1].
- Alaska Air Group (ALK) was initiated with a Neutral rating and a $49.00 price target by UBS Group [1].
- AvalonBay (AVB) was rated "Hold" by Evercore ISI with a price target of $229.00 [1].
- Benitec Biopharma (BNTC) was initiated with a "Buy" rating by TD Cowen [1].
- Broadridge Financial Solutions (BR) received a "Hold" rating from D.A. Davidson with a $220.00 target [1].
- Camden Property (CPT) was rated "Hold" by Evercore ISI with a price target of $124.00, implying a 13.26% upside [1].
- Citigroup (C) had a price target of $77.00 set by Evercore ISI, while Oppenheimer reiterated an "Outperform" rating [1].
- Coinbase Global (COIN) received a "Hold" rating from Goldman Sachs with a $268.00 price target [1].
- Coterra Energy (CTRA) was assigned a "Buy" rating by Barclays Capital with a $37.00 target [1].
- Crexendo (CXDO) was rated "Buy" at Northland Securities with a price target of $8.00 [1].
- Datadog (DDOG) had its price target raised from $150.00 to $175.00 by Bank of America, reiterating a "Buy" rating [1].
- DoubleVerify (DV) had its "Buy" rating reiterated by Craig Hallum [1].
- Emerson Electric Company (EMR) was rated "Buy" by TD Cowen, with a price target of $150.00 [1].
- Enovix (ENVX) received a "Buy" rating from Northland Securities with a $25.00 target [1].
- Enterprise Products Partners (EPD) was initiated with a "Hold" rating and a $33.00 price target by TD Cowen [1].
- Equity Residential (EQR) was upgraded by Evercore ISI from In-Line to Outperform, with a new target of $75.00, up from $74.00 [1].
- EQT Corp. (EQT) was initiated with an Overweight rating and a $65.00 target by Barclays [1].
- Essex Property (ESS) was rated "Hold" by Evercore ISI with a price target of $296.00 [1].
- Essent Group (ESNT) was downgraded from Outperform to Market Perform by Keefe, Bruyette & Woods, with a price target of $67.00 [1].
- Expand Energy (EXE) received a "Buy" rating from Northland Securities with a $25.00 target [1].
- First Republic Bank (FRC) was downgraded by Jefferies from Overweight to Hold, with a price target of $24.00 [1].
- Fiserv (FISV) was upgraded by Raymond James from Market Perform to Outperform, with a new target of $180.00, up from $175.00 [1].
- Five Below (FIVE) was rated "Hold" by Wedbush with a price target of $140.00 [1].
- Flextronics International (FLEX) was initiated with a "Buy" rating by Northland Securities with a price target of $15.00 [1].
- Global Payments (GPAY) was rated "Buy" by TD Cowen with a price target of $120.00 [1].
- HCA Healthcare (HCA) was rated "Buy" by TD Cowen with a price target of $340.00 [1].
Investors should remain cautious and monitor the stock closely for any changes in the technical indicators.
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema
SOBRE NOSOTROS
Nuestra historiaAutores de noticiasBase de conocimientosPolítica de privacidadTérmino de usoDescargo de responsabilidad de corretaje de tercerosTérminos de uso de AIMEDivulgaciones de riesgos de AInvest AICarrerasCONTÁCTENOS
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
Comentarios
Aún no hay comentarios